See more : Fractyl Health, Inc. Common Stock (GUTS) Income Statement Analysis – Financial Results
Complete financial analysis of Sanofi India Limited (SANOFI.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sanofi India Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Willow Lane Acquisition Corp. Unit (WLACU) Income Statement Analysis – Financial Results
- Arabian Plastic Industrial Company Limited (9548.SR) Income Statement Analysis – Financial Results
- Huafang Co.,Ltd (600448.SS) Income Statement Analysis – Financial Results
- Kelt Exploration Ltd. (KEL.TO) Income Statement Analysis – Financial Results
- Taeyoung Engineering & Construction Co.,Ltd. (009415.KS) Income Statement Analysis – Financial Results
Sanofi India Limited (SANOFI.NS)
About Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.51B | 27.70B | 29.25B | 28.69B | 30.14B | 27.42B | 24.70B | 23.42B | 21.76B | 19.64B | 18.01B | 15.69B | 12.30B | 10.85B | 9.74B | 9.83B | 8.74B | 8.84B | 8.08B | 7.35B |
| Cost of Revenue | 12.57B | 11.90B | 13.07B | 12.54B | 13.47B | 11.46B | 10.32B | 10.67B | 10.15B | 9.76B | 8.21B | 7.39B | 6.19B | 5.39B | 4.82B | 4.76B | 4.23B | 4.29B | 3.75B | 3.30B |
| Gross Profit | 15.94B | 15.81B | 16.18B | 16.15B | 16.66B | 15.96B | 14.38B | 12.75B | 11.61B | 9.88B | 9.80B | 8.30B | 6.10B | 5.46B | 4.92B | 5.07B | 4.51B | 4.55B | 4.32B | 4.05B |
| Gross Profit Ratio | 55.90% | 57.06% | 55.32% | 56.30% | 55.29% | 58.21% | 58.22% | 54.45% | 53.36% | 50.31% | 54.41% | 52.93% | 49.63% | 50.32% | 50.54% | 51.56% | 51.63% | 51.51% | 53.52% | 55.07% |
| Research & Development | 6.00M | 2.00M | 4.00M | 3.00M | 3.00M | 100.00M | 77.52M | 82.00M | 45.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.72B | 749.00M | 804.00M | 750.00M | 817.00M | 784.00M | 741.00M | 652.00M | 570.90M | 491.90M | 161.50M | 164.40M | 0.00 | 1.04B | 1.13B | 1.48B | 1.34B | 1.18B | 1.34B | 1.28B |
| Selling & Marketing | 409.00M | 1.68B | 1.60B | 1.68B | 2.00B | 1.96B | 1.83B | 1.55B | 1.53B | 1.41B | 1.81B | 1.58B | 0.00 | 1.70B | 1.38B | 811.46M | 672.31M | 581.84M | 247.40M | 234.09M |
| SG&A | 4.13B | 2.43B | 2.40B | 2.43B | 2.82B | 2.74B | 2.57B | 2.20B | 2.10B | 1.90B | 1.97B | 1.75B | 0.00 | 2.74B | 2.51B | 2.29B | 2.01B | 1.76B | 1.59B | 1.52B |
| Other Expenses | 0.00 | 6.75B | 6.82B | 7.38B | 8.17B | 7.99B | 20.00M | 16.00M | 15.00M | 113.70M | 118.70M | 116.20M | 3.27B | -29.89M | -1.01M | -187.27M | 272.12M | 282.81M | 364.42M | 337.38M |
| Operating Expenses | 4.13B | 9.18B | 9.22B | 9.82B | 10.99B | 10.74B | 10.02B | 8.72B | 8.13B | 7.41B | 6.74B | 6.08B | 3.27B | 3.06B | 2.51B | 2.10B | 2.28B | 2.05B | 1.96B | 1.85B |
| Cost & Expenses | 16.32B | 21.08B | 22.29B | 22.35B | 24.47B | 22.20B | 20.34B | 19.39B | 18.28B | 17.17B | 14.95B | 13.47B | 9.46B | 8.45B | 7.33B | 6.86B | 6.51B | 6.33B | 5.71B | 5.16B |
| Interest Income | 475.00M | 589.00M | 631.00M | 780.00M | 910.00M | 789.00M | 721.00M | 605.00M | 488.60M | 505.90M | 328.90M | 284.50M | 538.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 17.00M | 17.00M | 18.00M | 18.00M | 3.00M | 7.00M | 11.00M | 15.00M | 4.00M | 4.80M | 4.20M | 14.00M | 4.16M | 28.90M | 743.00K | 3.41M | 1.92M | 1.82M | 459.00K | 994.00K |
| Depreciation & Amortization | 396.00M | 419.00M | 667.00M | 822.00M | 999.00M | 1.03B | 1.02B | 1.19B | 1.13B | 966.40M | 922.60M | 898.70M | 311.45M | 197.36M | 173.44M | 182.14M | 184.54M | 178.47M | 171.81M | 168.39M |
| EBITDA | 8.87B | 9.08B | 13.26B | 7.61B | 7.00B | 7.13B | 6.17B | 5.99B | 5.10B | 3.56B | 4.16B | 3.52B | 3.15B | 2.54B | 2.59B | 2.78B | 2.37B | 2.64B | 2.51B | 2.36B |
| EBITDA Ratio | 31.10% | 28.01% | 28.39% | 28.08% | 25.26% | 26.07% | 25.07% | 25.56% | 23.49% | 20.46% | 24.97% | 22.50% | 25.73% | 23.65% | 26.59% | 28.35% | 27.64% | 30.37% | 31.43% | 32.15% |
| Operating Income | 12.19B | 7.34B | 7.64B | 7.24B | 6.61B | 6.12B | 5.17B | 4.67B | 3.98B | 3.05B | 3.57B | 2.63B | 2.85B | 2.37B | 2.42B | 2.61B | 2.23B | 2.51B | 2.37B | 2.19B |
| Operating Income Ratio | 42.77% | 26.50% | 26.11% | 25.22% | 21.95% | 22.33% | 20.93% | 19.96% | 18.30% | 15.54% | 19.85% | 16.77% | 23.19% | 21.83% | 24.81% | 26.50% | 25.53% | 28.35% | 29.30% | 29.86% |
| Total Other Income/Expenses | -3.74B | -2.59B | 1.09B | -4.29B | 326.00M | 872.00M | 783.00M | 641.00M | -12.00M | -3.17B | 509.30M | -14.40M | -12.52M | -20.54M | -3.17M | -8.16M | -1.92M | -8.79M | -3.09M | 67.08M |
| Income Before Tax | 8.46B | 8.64B | 12.58B | 6.77B | 6.00B | 6.10B | 5.15B | 4.66B | 3.97B | 3.06B | 3.63B | 2.62B | 2.84B | 2.34B | 2.41B | 2.60B | 2.23B | 2.50B | 2.36B | 2.26B |
| Income Before Tax Ratio | 29.66% | 31.20% | 43.00% | 23.61% | 19.91% | 22.24% | 20.83% | 19.90% | 18.25% | 15.58% | 20.16% | 16.68% | 23.09% | 21.57% | 24.78% | 26.41% | 25.51% | 28.25% | 29.26% | 30.78% |
| Income Tax Expense | 2.43B | 2.44B | 3.13B | 2.00B | 1.86B | 2.29B | 1.89B | 1.69B | 1.59B | 1.09B | 1.23B | 850.50M | 743.17M | 789.91M | 840.45M | 934.44M | 784.17M | 804.13M | 913.06M | 777.02M |
| Net Income | 6.03B | 6.21B | 9.44B | 4.78B | 4.14B | 3.81B | 3.26B | 2.97B | 3.21B | 2.64B | 2.65B | 1.77B | 1.91B | 1.55B | 1.57B | 1.66B | 1.44B | 1.69B | 1.45B | 1.48B |
| Net Income Ratio | 21.15% | 22.40% | 32.29% | 16.65% | 13.74% | 13.88% | 13.20% | 12.68% | 14.77% | 13.42% | 14.72% | 11.26% | 15.55% | 14.29% | 16.15% | 16.90% | 16.53% | 19.15% | 17.96% | 20.20% |
| EPS | 261.78 | 269.47 | 410.06 | 207.38 | 179.85 | 165.26 | 141.74 | 132.09 | 139.59 | 114.46 | 115.14 | 76.71 | 83.01 | 100.19 | 68.35 | 72.16 | 62.71 | 73.51 | 63.00 | 64.48 |
| EPS Diluted | 261.78 | 269.47 | 410.06 | 207.38 | 179.85 | 165.26 | 141.74 | 132.09 | 139.59 | 114.46 | 115.14 | 76.71 | 83.01 | 100.19 | 68.35 | 72.16 | 62.71 | 73.51 | 63.00 | 64.48 |
| Weighted Avg Shares Out | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M |
| Weighted Avg Shares Out (Dil) | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M | 23.03M |
Source: https://incomestatements.info
Category: Stock Reports